Agenda – Joint EMA-FDA workshop: Efficacy of monoclonal antibodies in the context of rapidly evolving SARS-CoV-2 variants Post author: Post published: Post category:Uncategorized Agenda – Joint EMA-FDA workshop: Efficacy of monoclonal antibodies in the context of rapidly evolving SARS-CoV-2 variants You Might Also Like Agenda – PRAC draft agenda of meeting 4-7 April 2022 CHMP PROM agenda for the meeting on 6 September 2021 Agenda – CAT agenda of the 17-19 February 2021 meeting
